New Guidelines Allow Some Patients With Chronic Myeloid Leukemia To Go Off Treatment
Most patients with chronic myeloid leukemia (CML) can live out their normal lives by taking tyrosine kinase inhibitors (TKIs). But mounting evidence also shows that roughly a third of those patients can eventually go off treatment altogether without their disease resurging.